Publications

5674 Results

Predictive Model of Aromatase Inhibitor Non-Adherence Using Patient-Reported Outcomes in Women with Breast Cancer (SWOG S1105)

Authors
D Hershman;A Moseley;K Arnold;G Hillyer;J Gralow;NL Henry;A Neugut;S Ramsey;J Unger
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 12019); American Society of Clinical Oncology 2020 Annual Meeting, poster discussion
Year
2020
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1105

Association of Molecular Expression Based Subtypes with Pathologic Response in a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer (SWOG S1314; NCT02177695)

Authors
S Lerner;D McConkey;C Tangen;J Meeks;T Flaig;X Hua;W Choi;S Daneshmand;A Alva;MS Lucia;D Theodorescu;A Goldkorn;M Milowsky;R Bangs;J Fowles;D Gustafson;I Thompson
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 5028); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Genitourinary
Study Number(s)
S1314

Beyond Patient-Level Barriers: Evaluation of Rural Residency and Area-Level Deprivation and Clinical Trial Participation

Authors
J Unger;A Moseley;G Doolittle;R Osarogiagbon;D Hershman
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr e19068); American Society of Clinical Oncology 2020 Annual Meeting, publication only
Year
2020
Research Committee(s)
Cancer Care Delivery and Cancer Survivorship
Study Number(s)
S0316

Transoral Robotic Surgical Resection followed by Randomization to Low- or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311)

Authors
R Ferris;Y Flamand;G Weinstein;S Li;H Quon;R Mehra;J Garcia;CH Chung;M Gillison;U Duvvari;B O'Malley;E Ozer;G Thomas;W Koch;M Kupferman;RB Bell;N Saba;M Lango;E Mendez;B Burtness
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 6500); American Society of Clinical Oncology 2020 Annual Meeting, LBA, oral
Year
2020

Primary Analysis of the Randomized Phase Ii Trial of Bortezomib, Lenalidomide, Dexamthasone with/without Elotuzumab for Newly Diagnosed, High Risk Multiple Myeloma (SWOG-1211)

Authors
S Usmani;S Ailawadhi;A Hoering;R Sexton;B Lipe;S Hita;J Zonder;M Dhodapkar;N Callandar;P Voorhees;B Durie;S Rajkumar;P Richardson;R Orlowski
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 8507); American Society of Clinical Oncology Annual Meeting (5/29-6/2/20, Chicago, IL), oral
Year
2020
Research Committee(s)
Myeloma
Study Number(s)
S1211

PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) vs. observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (EA8143): A trial of the ECOG-ACRIN Cancer Research Group

Authors
L Harshman;A Puligandla;N Haas;M Allaf;C Drake;D McDermott;S Signoretti;D Cella;R Gupta;B Shuch;T Choueiri;P Lara;A Kapoor;D Heng;M Jewett;V Master;M Michaelson;B Leibovich;D Maskens;M Carducci
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr TPS5101); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/EA8143

Lung-MAP (SWOG S1400): Design, implementation, and lessons learned from a biomarker-driven master protocol (BDMP) for previously treated advanced squamous lung cancer (sqNSCLC)

Authors
M Redman;V Papadimitrakopoulou;K Minichiello;D Gandara;F Hirsch;P Mack;L Schwartz;E Vokes;S Ramalingam;N Leighl;J Bradley;M LeBlanc;S Malik;V Miller;E Sigal;S Adam;CD Blanke;K Kelly;RS Herbst
Journal / Conference
J Clin Oncol 38: 2020 (suppl; abstr 9576); American Society of Clinical Oncology 2020 Annual Meeting, poster
Year
2020
Research Committee(s)
Lung
Study Number(s)
S1400

Racial Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the NCI Compared to Pharmaceutical Companies

Authors
J Unger;D Hershman;R Osarogiagbon;A Gothwal;S Anand;NA Dasari;M Overman;J Loree;K Raghav
Journal / Conference
American Association for Cancer Research (June 22, 2020, virtual meeting), poster
Year
2020
Research Committee(s)
Cancer Care Delivery

SWOG S1320: Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma

Authors
A Algazi;M Othus;A Daud;R Lo;J Mehnert;T-G Truong;R Conry;K Kendra;G Doolittle;J Clark;M Messino;D Moore;C Lao;B Faller;R Govindarajan;A Harker-Murray;L Dreisbach;J Moon;K Grossmann;A Ribas
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA), oral
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
S1320

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Small Bowel Cancer Cohort

Authors
YK Chae;M Othus;SP Patel;M Zalupski;A Kasi;M Khalil;A Kalyan;B Polite;S Fenton;S Gurung;C McLeod;F Giles;HX Chen;E Sharon;E Mayerson;M Plets;C Ryan;CD Blanke;R Kurzrock
Journal / Conference
American Association for Cancer Research Annual Meeting (April 24-29, 2020, San Diego, CA), oral
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609